Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
Federica Fogacci, Young Fellow at European Atherosclerosis Society, shared on LinkedIn:
”On 17 November, I had the pleasure of taking part in the EAS Lipoprotein(a) Workshop, organized by the European Atherosclerosis Society with the support of Novartis and Fondazione SISA.
It was a highly stimulating opportunity to share experiences on the role of Lp(a) in cardiovascular risk and to further strengthen collaboration within the Lp(a)CCELERATE study.
I left the meeting with clearer ideas, fresh perspectives and – above all – the feeling of being part of a community of colleagues genuinely committed to improving CvPrev
Many thanks to the organizers and to all participants for their questions, insights and openness in building the next steps of this journey together.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 18:12Adil Nawaz: Extended Dual Antiplatelet Therapy After Coronary Stenting
-
Oct 16, 2026, 17:50Elad Asher։ STORM-PE Shows Functional Benefits of Thrombectomy
-
Oct 16, 2026, 17:32Shruthi Narayan: STORM-PE and STRIKE-PE Studies Advance Understanding of Recovery After Pulmonary Embolism
-
Oct 16, 2026, 17:22Wolfgang Miesbach։ What a Near-Perfect FISH Score Fails to See
-
Oct 16, 2026, 17:06Troels Wienecke: Connecting Myeloproliferative Disease and Ischemic Stroke
-
Oct 16, 2026, 17:03Only 5 Days Left to Submit Your Research for EAHAD 2027
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand